Materials and Methods: The patient flow from referral, through the diagnostic procedures and through surgical treatment is described.
INTRODUCTION
Breast cancer is the most common cancer among women and accounts for one quarter of all female cancer in the western countries. The evaluation and diagnosis of breast cancer is followed by ahigh level of stress in most patients (1). Thus ac ost-effective and humane way of handling symptoms and signs, including findings in mammography screening (45-69 years of age), is of paramount importance. In this paper we will describe the logistics followed in our hospital for our approximately 800 new referrals a year of whom slightly above half turns out to have an infiltrating or in situ carcinoma. Logistics of breast cancer diagnosis and treatment PATHWAYS OF REFERRAL Before mammography screening started in Oslo in 1996, 70 %ofreferred cases to our hospital were palpable lesions, 62 %w ere tumours detected by the women themselves, 8%b yd octors. 17 %h ad other symptoms and 9%f indings by routine mammography and thus mainly not palpable. All were referred to the hospital by their general practitioner (GP). During the first screening round 1996/97 half of the cancers were picked up directly by the screening and there was ashift towards 70 %non-palpable lesions. The screening detected cancers were referred for surgery directly and not through the GP.
PRINCIPLES OF THE DIAGNOSTIC ASSESSMENT AND INDICATION FOR OPEN SURGERY
Diagnostic work-up of women with breast symptoms is based on the triple diagnostic approach: Clinical examination (inspection and palpation), imaging (mammography and ultrasound), and percutaneous needle biopsy. For all methods the examinator records the results on as cale from one to five (Table 1). An optimal diagnostic setting is given when the radiologist and pathologist are working together in ab reast diagnostic centre. This provides an immediate reporting («single visit diagnosis»). Furthermore, arepuncture can be performed if there should be adiscrepancy between imaging diagnosis and preliminary result of the fine needle aspiration cytology (FNAC).
Mammography is the basic imaging modality and should always be performed in women with ap alpable lump. It is so far the only way to detect unsuspected breast cancer at an early preclinical stage in asymptomatic women. The imaging work-up of a palpable mass has several purposes: Amore precise definition of the nature of the mass; to detect unexpected ipsilateral or contralateral cancer; and to identify an onpalpable extensive intraductal component and thus reduce the possibility of recurrence after breast conservation therapy. The sensitivity of mammography dependsonthe breast parenchyma: High sensitivity (about 90-95 %) in fatty breasts and considerably lower (about 60-75 %) in dense breasts (2). It should be emphasized that the purpose of mammography is not to defer biopsy of ac linically suspicious mass. Abasic algorithm guideline for the evaluation of apalpable mass is presented in Fig. 1 . Ultrasonography (US) has emerged as the single most valuable adjunct to mammography in patients with nonconclusive mammographic findings (3). If a palpable mass is not seen on mammography or the mammographic examination is nonconclusive, the patient should always be evaluated with US ( Fig.1 ). The US examination should determine whether the mass is asimple cyst, acomplex cyst, or asolid mass. If apalpable mass meets the criteria for asimple cyst, no further work-up is necessary. If the cyst is painful, of concern to the patient, or has an echogenic content, cyst aspiration can be performed. If the cyst is complex, having both cystic and solid components, an intracystic tumour should be included in the dif-ferential diagnosis. Extensive US feature analysis has been shown to have ahigh negative predictive value of 96-98 %(3), and US may possibly obviate the need for excision in as ubgroup of patients with definite benign tumour findings on ultrasound. US is also the most important adjunct to mammography in cases of nonpalpable equivocal mammographic masses and densities and our basic algorithm guideline for the evaluation of anonpalpable mammographic finding is presented in Fig. 2 .
MR has emerged as an important modality due to its high sensitivity (about 96-98 %) in invasive cancers. The most important indications for breast MRI are differentiation between scarring tissue and local recurrence in patients after BCT, preoperative staging of women candidates for BCT and mammographic dense parenchyma, women with axillary lymph nodes metastases of unknown origin, and in future perhaps screening of women with ah igh risk of breast cancer (4) FNAC of both palpable and non-palpable breast lesions have been shown to be reliable and cost-effective. FNAC has been replaced by core-needle biopsies in many institutions. One of the reasons for this is the uncertainty in differentiating between ductal carcinoma in situ and invasive carcinoma. Afew studies (5,6) have described criteria that allow differentiation between ductal carcinomainsitu (DCIS) and invasive carcinoma in up to 50 %ofthe cases (5) and with ap ositive predictive value (PPV) of 96 %. Another approach is to try to differentiate between in situ and invasive carcinoma, in particular by applying specific criteria for DCIS and papillary carcinoma (7). This strategy on reporting in situ and invasive carcinoma has enabled ad irect diagnosis of 91.8 %o ft he invasive carcinomas as invasive by FNAC.
Smear quality is of extreme importance as it affects the number of equivocal and "suspicious" cytological diagnoses. Inadequacy rate should be less than 10 %. In our institution, the pathologist participates in aspiration of all lesions, also the non-palpable ones. The combination of FNAC and mammography/ultrasound results allowed definitive management of about 75 %o ft he women with mammographic and/or ultrasound findings requiring further investigation of the rest (7).
Clinical examination is the least sensitive and specific examination. Of 4436 patients with breast symptoms examined in the years 1988-95, clinical examination revealed as uspicious lesion in 101 while the other tests found them benign or normal (Table 2) . On biopsy 7h ad cancer. Clinical examination of the axillae is also rather fallacious as cancer is found in 30-50 per cent of clinical negative axillae and 25-47 percent of clinical positive axillae turns out to be negative on histological examination after axillary clearance (8). This is afact to bear in mind when one contemplates to avoid sentinel node due to clinically positive axillae and has lead us to use FNAC on such glands. If there are no signs of cancer cells and if lymphoid cells are found to prove that the lymph node was hit, we use sentinel node technique even on clinically suspicious palpable glands. Our basic rule of the triple diagnostic evaluation is that if any one or combinations of the components reaches the level of as uspicious lesion -3 ,s urgery is indicated.Wedo, however, differentiatebothtype of surgery and anaesthesia according to the level of suspicion (Table 2 ). If only mammography/ultrasound and/or clinical examination reveals suspicious findings while cytology is benign -1, 2o re quivocal -3 ,w ew ill do ad iagnostic biopsy (marked if the lesion is non-palpable) mainly in local anaesthesia and sedation (see below). Our definition of diagnostic biopsy is that we aim at getting the lesion out, but not with wide margins. If cytology is classified as suspicious for malignancy or in situ grade III -4,we will do as entinel node procedure in addition to the wide excision aiming at free margins by adding 10-15 mm in all directions to the width of the lesion as palpated or measured on non-palpable lesions, but avoid ablatio mammae as we occasionally observe that final histological diagnosis is benign. If cytology is classified as invasive lesion -5w ith any combination of the examinations, we do radical surgery, breast conserving (BCT) or ablatio mammae according to the patients preference. This is done without further histology proof of the cancer adding sentinel node when that is indicated (see below).
1988-95 (without screening) final diagnosis infiltrating carcinoma (IC) was given to 1169 and ductal carcinoma in situ (DCIS) to 63 (5 %). In 1996-1999 (symptomatic and screening) we diagnosed 1404 infiltrating carcinomas and 178 DCIS (10 %). In this period of time we had 3f alse positive cytologies of infiltrating carcinoma. One of them has, however developed ER/PGR positive metastasis and thus is not at rue false positive, but am iss to find the cancer in the removed breast. Another was am iss in the routinesinthe surgical department as cytology was taken elsewhere and diagnosis was not revised in our laboratory as it should have been. On revision postoperatively cytology demonstrated av ery homogenous cell population, but with ah igh degree of dissociation, well in accordance with the infra mammary lymph node found in the breast. All together FNAC false positive rate of infiltrating carcinoma during the period 1988-99 has been 1.2 pro mille.
IN HOSPITAL MANAGEMENT
The cornerstones in our handling of breast symptoms and signs is triple diagnostic procedures, once weekly consensus meetingofall involved specialities,day care surgery, routine sentinel node technique and use of patient hotel to avoid stay in ordinary wards.
Our goal is that any symptomatic patient shall have af inal decision on whether surgery has to be done no later than 15 working days after referral is received. Screening patients receive their recall appointment, if needed, the first Monday after screening images have been taken and have their decision about surgery no later than Friday the same week. Time to surgery is set to maximum 15 working days (occasionally not met due to lack of capacity).
Every Thursday afternoon at least one representative from the specialities involved meet, and the results from the same week's diagnostic procedures and the histology results from surgery 3-4 weeks before are reviewed. Final decisions on further treatment and follow up is decided and documented in the patient record. This meeting thus is av ery important quality assurance on the individual examinators conclusions.
All surgery, except af ew (10-20 ay ear) with severe cardiopulmonary problems (ASA 3-5) and dementia, has since May 2000 been done as day care surgery. As outlined in Table 2 , local anaesthesia with sedation is used for most biopsies and wide excisions where sentinel node biopsy is not needed. These patients return home after af ew hours observation in the day care unit. The same is the case when we have done aw ide excision and an egative sentinel node examination. In the period June 2000 to April 2002 735 patients were operated in the day surgery unit. 223 (30 %) were transferred to the hotel, 512 (70 %) went home. The main reason for these results is the mammography screening. In the first round we had only 20 %a xillary node metastasis (all patients had complete axillary node clearance (ANC)) and more than 50 %BCT (9).
Those who have the breast removed with or without ANC or have aw ide excision with ANC, are transferred to the patient hotel 3-4 hours after surgery is finished. They stay in the hotel till their drains can be removed one to four days after surgery. The hotel is situated on the hospital campus and at a short indoor distance from our surgical outpatient clinic. Thus the patients are able to walk to the clinic to have their dressings changed and their drains emptied. Security, both at home and in the hotel is taken care of by our demand that there shall be an adult person with the patient the first night after surgery. Registered nurses are available on call at all times in the hotel. In our two years of experience no more serious events than af ew haematomas in the breast and one patient who fainted in the restaurant of the hotel has been noted. Preliminary result of an ongoing patient satisfaction examination reveals that 37/46 are satisfied or very satisfied with their experience and 41/46 would recommend this type of care to other women with breast cancer. Only 2/46 had had difficulties finding ap erson to stay with them the first night after surgery.
Avery important part of this logistic is the type of anaesthesia used. All the patients receive an oral priming dose of paracetamol 1-2 gr. and rofecoxib 37,5-50 mgr. after the arrival in the department unless contraindicated. The classical premedication with sedative/anxiolyticum is usually avoided due to long acting sedative effects (10) . Minor surgical procedures are performed predominantly in local infiltration with lidocaine 10 mg/ml, 10-20 ml supported by alight i.v. sedation with remifentanil 0.05-0.15 microg/kg/min and propoferol 0.2-0.3 microg/ml by at argeted control infusion system (TCI, Diprifusor). By the end of the procedure bupivacaine 2.5 mg/ml, 10-15 ml is infiltrated in the wound.
Major procedures such as ablation, sentinel node detection and axillary clearance are performed in general anaesthesia with remifentanil 0.1-0.3 microg/kg/min and propofol/ 1.5-2.5 microg/ ml TCI. and assisted ventilation with 65 %n itrous oxide in oxygen through alaryngeal mask. They also receive dexamethasone 4m gi .v. as prophylaxis for nausea, vomiting and pain (11) as well as bupivacaine infiltration in the wound. Ap atient with ah istory of transportation sickness or previous postanaesthetic nausea or vomiting, are given onsedantron 4mgand droperidol 1mg i.v. as further prophylaxis.
In the postoperative care unit pain is initially treated with small doses of fentanyl 25-50 microgr during the first 1-2 hours. Occasional shivers are treated with pethidine 25-50 mg i.v. Nausea and vomiting is treated with metoclopramide 10 mg i.v. or ephedrine 5-10 mg i.v.
After 1-2 hours al ight meal is offered. Six hours after the preoperative dose paracetamol 1g supplemented with codeine 60 mg if the patient has medium or much pain. NSAIDS other than paracetamol andc ox 2-i nhibitorsa re avoided, considered the risk of post surgical bleeding. Against strong pain after 2h ours the opioid oxycodon in as low release oral formulation or the shorter acting tramadol 50 mg may be used.
When leaving the department, patients who have undergone minor surgery are supplied with paracetamol 1g +codeine 60 mg × 3and rofecoxib 50 mg × 1for three days. After major surgery the "discharge package" contains the above plus metoclopramide for rectal administration and ashort acting tranquilliser i.e. zopiclone 5mgfor the first night.
All patients are telephoned on the first postoperative dayf or interviewo nt heir generalw ellb eing, practical problems, pain, nausea and other complaints.
In alearning period we did 75 sentinel node cases with completing ANC. In May 2000 we decided to use the technique as routine with exclusion criteria as seen in Table 3 . Until April 2002 we have done 357 cases of which 72 (20 %) has been positive giving rise to ANC. 54 of the sentinel nodes was positive by peroperative frozen sections and/or imprint cytology and 18 on final histology while peroperative examinations were negative. We have had two cancer events in sentinel node negative axillae so far, a rate of 1/179. This way of handling breast cancer is highly costeffective. 80 %ofthe cases are day surgery cases with no need for ah ospitalisation and one third of these cases does not need general anaesthesia. In comparison all patients except a6 0-80 diagnostic biopsies were in-patients before we established this logistic. All patients with infiltrating carcinoma had ANC and were in the ward till the drain was removed with an average stay of 5d ays. Cost per day per patient in the ward is presently approximately 265 euro (EUR) while in the hotel 53 EUR. With approximately 320 patients with infiltrating carcinoma ayear, total cost would be 424 000 EUR with our former logistic. Our present cost 320:5 (one fifth to sentinel node) × 4 (days post operatively in the hotel) × 53 =1 35 68 EUR. As the first night in the hotel is free also for the person that follow the patient 320:5 × 53 =33 92 EUR must be added to the hotel cost which then totals 16 960 EUR. In this crude estimate we have not taken into account the savings we have in the less use of general anaesthesia and the higher efficacy we observe in the day surgery unit (average four patients per theatre per day) as compared to the general operation theatre (three patients). Anyhow ac ost reduction of more than 400 000 EUR ay ear is as ignificant amount.
TAKING CARE
It is observed that 30-40 %o fb reast cancer patients have measurable depression and anxiousness and that good postoperative care can reduce these problems (14) . Thus we have been met with the argument that our logistic leave the patients very much on their own which may increase their stress problems. To counter this we employ two specialised cancer nurses. Every patient gets ac ard with their name and phone number when cancer diagnosis is given, and are encouraged to phone when need is felt. On the day of the consensus meeting one of the nurses phones the patients, informs them of the final result and offers further support. For those who need it, a consultation with the doctors is arranged the next day. Finally the nurses, on av oluntary basis, invite patients with breast cancer diagnosis to postoperative follow-up groups. Five to eight patients meet with nurses and doctors to discuss their problems. At one of these meetings amember from "The society of breast cancer operated", as ubgroup of "The Norwegian Cancer Society", is present and informs about their activities. All together we feel that this morethancompensates for the few daysthe patients have lost of care in the ward and that we are taking well care of our patients. The patient satisfaction study reveals that 37/46 were satisfied or very satisfied with the information at first consultation, and 35/46 by the experience on the day of surgery. EUR. This is mainly due to the fact that 80 %o ft he patients can return home the day of operation, but also because cost per day in the hotel is only one fifth of the cost in the wards. One could of course argue that even the hotel is not necessary and that all breast cancer patients, even those with drains, may return home early or even that drains are not necessary (14) . We have tried out these tactics, but find low acceptance of returning home with drain, and close to 40 %with seromas after ANC when drains are not used. Even suturing the flaps does not reduce the seroma tendency and also in hospital stay after ANC is only slightly reduced (14) . The tactic we have chosen has ahigh degree of acceptance.
In our opinion the most important factor in succeeding with this logistic is the type of anaesthesia and postoperative pain treatment chosen (10, 11) . We especially emphasize our consequent use of al ongacting local anaesthesia in the wound edges as an important step in avoiding unacceptable postoperative pain.
Routine use of sentinel node technique is debatable. After two years of experience with 357 cases with primarily negative sentinel node we have experienced two cases of lymph node metastasis in the homolateral axilla. Such events are to be expected as most studies observe false negative sentinel nodes when simultaneous ANC is done (14) . The question is what the acceptable level of such events may be. Our suggestion would be less than 1%after 5years of observation. False negative patients will to alarge extent be denied the postoperative adjuvant therapy; they would have had if ANC had been done. Adjuvant therapy would have reduced their approximate 50 %r isk of death after surgery alone by one third. Acceptance of a1%level of false negative will give rise to 1/100:2:1/3 =1 /300 extra deaths in the population at risk. We feel this is acceptable, especially as it is lower than the extra deaths our present cut-of levels for adjuvant therapy in node negative cancer gives (1-2/100).
Aq uestion with similar moral implications is whether our practice of doing radical surgery on FNAC malignancy diagnosis alone (with no histology proof) is acceptable. Over a1 4-year period we have experienced af requency of 1.2 pro mille false positive cytology's leading to radical surgery. The question is whether other tactics could have avoided this.Certainly by doingopensurgicalbiopsypre-operatively on all cases. Due to the high cost and large number of unnecessary benign biopsies this tactic has been left in most countries. Many recommend the use of core needle or Mammotome biopsies, especially in cases with non-palpable micro calcifications. Even these techniques, however, do not totally eliminate the possibility of false positive cases (15) . When cost-efficacy is entered into the evaluation, FNAC is highly competitive as the cost per examination is less than 1EUR compared with core needle biopsy approximately 22 EUR and aM ammotome biopsy close to 370 EUR (plus cost of an investment of 300 000 EUR). As we do more and more breast conserving therapy, and sentinel node technique per definition prevents unnecessary ANC, the consequence of afalse positive FNAC also diminishes. As long as our highly qualified cytopathologists can keep the present level of false positive FNAC, we will therefore carry on with that as our only preoperative tissue examination. We will, however, maintain a vigilant observation of our false positive rate, and are of the opinion that all departments using this tactics should do so. Cytology of breast cancer is avery subtle examination and skilled cytopathologists are needed. We are also of the opinion that our weekly quality assurance meetings help to avoid the very unpleasant false positive diagnosis.
Last, but not least, afew comments on the "taking care" aspect of breast cancer diagnostics and treatment. The high level of stress among breast cancer patients (1,12) is often underestimated as well as the proven effect of psychosocial intervention (12) . One of the benefits of our cost-effective way of handling breast cancer patients is that we thus can defend the expenses we have on our two cancer nurses. They are very valuable to the patients' well being, but not cost-effective in the strict sense of the word. We are of the opinion that every department treating breast cancer should have such nurses.
